Category: Moderna

‘This Is Beyond My Expectations,’ Champagne Says of Canadian Biomanufacturer Rebound

OTTAWA—Innovation Minister Francois-Philippe Champagne says Canada’s biomanufacturing sector has rebounded beyond his initial expectations in the last several months, as a Canadian drug maker stands poised to bring positive results from the first plant-based COVID-19 vaccine to Health Canada. At the outset of the pandemic, Canada’s lack of biomanufacturing capability came into sharp focus, and…


Moderna President Says All Vaccines’ Efficacy May Struggle Against Omicron

Moderna President Stephen Hoge said there is a risk that existing COVID-19 shots may struggle in their effectiveness against the Omicron variant, though it’s too early to say by how much. Hoge’s comments follow those of Moderna’s Chief Executive Officer Stéphane Bancel, who said last week that he predicts current vaccines will be far less effective against the…


What Do We Know About Omicron?

It’s been just days since a new strain of COVID-19 made headlines across the planet. While the World Health Organization (WHO) has warned that the new Omicron variant presents a “very high risk,” other scientists, including some with WHO, have stressed that we still have much to learn about the new CCP (Chinese Communist Party)…


Moderna Could Have Omicron Booster Shot Ready to File for FDA Authorization by March

Moderna President Stephen Hoge said Wednesday that the company could have a COVID-19 booster shot to combat the newly-discovered Omicron variant tested and ready to file for U.S. authorization as soon as March. Boosters carrying genes specifically to combat mutations in the variant could be the quickest way to address any effect it may have on the…


Moderna CEO Says New COVID-19 Vaccines May be Need to Counter Omicron

Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…


Moderna CEO Says New COVID-19 Vaccines May be Needed to Counter Omicron

Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…


Moderna Joins World’s Major COVID-19 Vaccine Manufacturers in Race to Rework Vaccine for Omicron

Moderna has joined the world’s major manufacturers of COVID-19 vaccines in the race to investigate the new Omicron variant and adapt their shots to combat the new strain, which has a high number of mutations and appears to spread rapidly. Speaking on the BBC’s “Andrew Marr Show” on Sunday, Moderna’s chief medical officer Paul Burton said that…


Biden Administration Announces Plan to Ramp up Vaccine Manufacturing

The Biden administration announced plans to spend billions of dollars to ramp up United States vaccine production. Officials said on Nov. 17 that the Department of Health and Human Services (HHS) will reach out to mRNA vaccine manufacturers to identify opportunities to scale up production with the goal of increasing capacity to a billion doses…


Moderna Asks FDA to Authorize COVID-19 Vaccine Boosters for All Adults

Moderna on Wednesday asked U.S. drug regulators to widen authorization for additional doses of its COVID-19 vaccine. The Massachusetts-based biotechnology firm wants every American 18 or older to be able to get a booster. The Food and Drug Administration (FDA) recently allowed boosters of the Moderna and Pfizer COVID-19 vaccines, which both have two-shot primary…


Pfizer, BioNTech, Moderna Making $1,000 Every Second From COVID-19 Vaccines: People’s Vaccine Alliance

Pfizer, BioNTech, and Moderna are making thousands of dollars in combined profits every minute from their COVID-19 vaccines, while less than 1 percent of each company’s doses have gone to the world’s poorest countries, according to a new analysis by the People’s Vaccine Alliance (PVA). PVA, a coalition of organizations campaigning for wider access to COVID-19 vaccines, based its calculations…